Intermediate cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis successfully treated with fluconazole

Clinical and Experimental Dermatology

Volumn 39, Issue 6, 2014, Pages 708-712

  Daly, K ^a   De Lima, H ^b   Kato, H ^c   Sordillo, E M ^d   Convit, J ^b   Reyes Jaimes, O ^b   Zerpa, O ^b   Paniz Mondolfi, A E ^a,b,e  

^a Unidad Experimental de Inmunoterapia   (Venezuela)

^b INSTITUTO DE BIOMEDICINA   (Venezuela)

^c HOKKAIDO UNIVERSITY   (Japan)

^d ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AETERNA; ALKALINE PHOSPHATASE; CYTOCHROME B; FLUCONAZOLE; HEAVY METAL; MEGLUMINE ANTIMONATE; MILTEFOSINE; RIBOSOME RNA; UNCLASSIFIED DRUG; ANTIFUNGAL AGENT;

ABDOMINAL PAIN; ABSENCE OF SIDE EFFECTS; ALKALINE PHOSPHATASE BLOOD LEVEL; CASE REPORT; CHILD; CLINICAL TRIAL (TOPIC); CONTAMINATION; DISEASE SEVERITY; DRUG WITHDRAWAL; ENDEMIC DISEASE; ERYTHEMA; FACE; FEMALE; FOREARM; HUMAN; HUMAN TISSUE; LEISHMANIA BRAZILIENSIS; LEISHMANIN SKIN TEST; LIMB; LOCAL THERAPY; MEDICAL HISTORY; NAUSEA; NOSE DISEASE; NOSE MUCOSA; PAPULE; PRIORITY JOURNAL; RASH; REVIEW; SCAPULA; SCHOOL CHILD; SIDE EFFECT; SKIN BIOPSY; SKIN DEFECT; SKIN LEISHMANIASIS; SKIN MANIFESTATION; SKIN PAIN; SKIN ULCER; SMEAR; VOMITING; LEISHMANIASIS, CUTANEOUS; PARASITOLOGY; TREATMENT OUTCOME;

ANTIFUNGAL AGENTS; CHILD; FEMALE; FLUCONAZOLE; HUMANS; LEISHMANIA BRAZILIENSIS; LEISHMANIASIS, CUTANEOUS; TREATMENT OUTCOME;

EID: 84904444219     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/ced.12359     Document Type: Review

References (14)

1. Paniz Mondolfi AE, Duffey GB, Horton LE, et al,. Intermediate/borderline disseminated cutaneous leishmaniasis. Int J Dermatol 2013; 52: 446-55.
2. Kato H, Watanabe J, Mendoza Nieto I, et al,. Leishmania species identification using FTA card sampling directly from patients' cutaneous lesions in the state of Lara, Venezuela. Trans R Soc Trop Med Hyg 2011; 105: 561-7.
3. Blum J, Lockwood DN, Visser L, et al,. Local or systemic treatment for New World cutaneous leishmaniasis? Re-evaluating the evidence for the risk of mucosal leishmaniasis. Int Health 2012; 4: 153-63.
4. Romero GA, Flore MRM, Noronha EF, Macêdo Vde O,. High frequency of skin reactions in patients with leishmaniasis treated with meglumine antimoniate contaminated with heavy metals. A comparative approach using historical controls. Mem Inst Oswaldo Cruz 2003; 98: 145-9. (Pubitemid 38019666)
5. González U, Pinart M, Renginfo-Pardo M, et al,. Interventions for American cutaneous and mucocutaneous leishmaniasis. Cochrane Database Syst Rev 2009; 2: CD004834.
6. Sousa AQ, Frutuoso MS, Moraes E, et al,. High-dose oral fluconazole therapy effective for cutaneous leishmaniasis due to Leishmania (Vianna) braziliensis. Clin Infect Dis 2011; 53: 693-5.
7. Morizot G, Delgiudice P, Caumes E, et al,. Healing of Old World cutaneous leishmaniasis in travelers treated with fluconazole: drug effect or spontaneous evolution? Am J Trop Med Hyg 2007; 76: 48-52. (Pubitemid 351627801)
8. Schnedl J, Auer H, Fischer M, et al,. Cutaneous leishmaniasis-an import from Belize. Wien Klin Wochenschr 2007; 119: 102-5.
9. Crogan J, Gunasekera H, Wood N, et al,. Management of old world cutaneous leishmaniasis in refugee children. Pediatr Infect Dis J 2010; 29: 357-9.
10. Sklavos AV, Walls T, Webber MT, Watson AB,. Cutaneous leishmaniasis in a child treated with oral fluconazole. Australas J Dermatol 2010; 51: 195-7.
11. Baron S, Laube S, Raafat F, Moss C,. Cutaneous leishmaniasis in a Kosovan child treated with oral fluconazole. Clin Exp Dermatol 2004; 29: 546-7. (Pubitemid 39278207)
12. Toubiana J, Armengaud JB, Dupouy Camet J, Gendrel D,. Oral fluconazole treatment for extensive cutaneous leishmaniasis in an 11-year-old child. Pediatr Infect Dis J 2006; 25: 1083-4. (Pubitemid 44657826)
13. Rangel H, Dagger F, Hernandez A, et al,. Naturally azole-resistant Leishmania braziliensis promastigotes are rendered susceptible in the presence of terbinafine: comparative study with azole-susceptible Leishmania mexicana promastigotes. Antimicrob Agents Chemother 1996; 40: 2785-91. (Pubitemid 26404344)
14. Beach DH, Goad LJ, Holz GG,. Effects of antimycotic azoles on growth and sterol biosynthesis of Leishmania promastigotes. Mol Biochem Parasitol 1988; 31: 149-62.